Journals
Publish with us
Publishing partnerships
About us
Blog
Mediators of Inflammation
Journal overview
For authors
For reviewers
For editors
Table of Contents
Special Issues
Mediators of Inflammation
/
2023
/
Article
/
Tab 4
/
Review Article
The Clinical Application and Progress of Mirogabalin on Neuropathic Pain as a Novel Selective Gabapentinoids
Table 4
Dose of mirogabalin following renal impairment (creatinine clearance (CL
cr
) : L/min).
Mirogabalin
Mild (
)
Moderate (
)
Severe (including ESRD) (
)
Daily dose
10-30 mg
5-15 mg
2.5-7.5 mg
Initial dose
5 mg BID
2.5 mg BID
2.5 mg QD
Fixed dose
15 mg BID
7.5 mg BID
7.5 mg QD